Product Information

TERIFLUNOMIDE 7 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.2917 per EA under NDC 62332031330. Its NADAC has been published 118 times since May 22, 2024.

FDA first approved this application on Apr 19, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TERIFLUNOMIDE 7 MG TABLET

TERIFLUNOMIDE
$0.2917per EA

Strength

7 mg/1

NDC

62332031330

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TERIFLUNOMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA209572

FDA Approved

4/19/2019

TE Code

AB

On Market Since

1/25/2023

Pharmacological Classes

Dihydroorotate Dehydrogenase Inhibitors
Pyrimidine Synthesis Inhibitor

Price Statistics

The NADAC for TERIFLUNOMIDE 7 MG TABLET has been published 118 times since May 22, 2024, and over the history we have for it it has declined 51.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2917 per EA
All-time high$0.6572 (Mar 11, 2026)
All-time low$0.2917 (Aug 19, 2026)
52-week high$0.6572
52-week low$0.2917
Median price$0.5460
Average price$0.5203
Largest weekly change-28.7% (May 20, 2026)
Weeks tracked118
Tracking sinceMay 22, 2024

Price History

1W

-1.8%

1M

-8.8%

3M

-10.6%

6M

-55.6%

1Y

-49.1%

3Y

N/A

5Y

N/A

All

-51.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the TERIFLUNOMIDE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of TERIFLUNOMIDE 7 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TERIFLUNOMIDE 7 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.2917 per EA (NDC 62332031330), effective Aug 19, 2026.

How has the price of TERIFLUNOMIDE 7 MG TABLET changed over time?

Over the history we have for it, the NADAC for TERIFLUNOMIDE 7 MG TABLET has declined 51.8%. It has been tracked across 118 weekly CMS publications since May 22, 2024.

What are the highest and lowest recorded NADAC prices for TERIFLUNOMIDE 7 MG TABLET?

Since May 22, 2024, the NADAC for TERIFLUNOMIDE 7 MG TABLET has ranged from a low of $0.2917 (Aug 19, 2026) to a high of $0.6572 (Mar 11, 2026), with a median of $0.5460 per EA.

Are there cheaper alternatives to TERIFLUNOMIDE 7 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of TERIFLUNOMIDE 7 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures TERIFLUNOMIDE 7 MG TABLET?

TERIFLUNOMIDE 7 MG TABLET (NDC 62332031330) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.